FENNEC PHARMACEUTICALS INC. cotiza a 10.72 USD y tiene una capitalización bursátil de $376M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncolo…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $0.01 | $-0.10 |
| Estimado | $0.15 | $0.02 | $-0.02 | $0.04 |
| Sorpresa | — | — | +150.0% | -350.0% |
| Métrica | FENC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -14.1% | -38.6% | +24.5% |
| Net Margin | -21.8% | -33.6% | +11.7% |
| FCF Margin | — | -13.9% | — |
| ROE | -27.5% | -40.4% | +12.9% |
| ROA | -13.8% | -32.0% | +18.2% |
| Current Ratio | 6.37 | 2.84 | +3.53 |
| Debt / Equity | — | 0.28 | — |